Lytix Biopharma

Lytix Biopharma Publishes Comprehensive Review on the Transformative Potential of Oncolytic Peptides in Leading Cancer Journal (JITC)

17 February 2026 -- Oslo, Norway -- Lytix Biopharma AS, a clinical-stage immuno-oncology company, today announced the publication of a review article in the Journal of ImmunoTherapy of Cancer (JITC). The article, “Immunobiological mechanisms of action of oncolytic peptides,” was created in collaboration with the company’s scientific collaborators at the Institut Gustave Roussy (France) and...
Sandakerveien 138, 0484 Oslo, Norway